Ozgur Ozyuncu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ozgur Ozyuncu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Doruk Katlan
2 shared publicationsEmirhan Nemutlu
2 shared publications- Mehmet Sinan Beksac
Hacettepe University
2 shared publications Sedef Kir
2 shared publicationsArbay Ozden Ciftci
1 shared publication- Derman Basaran
E Department of Gynecology and Obstetrics , Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital , Ankara , Turkey
1 shared publication
Latest Publications
- 12 August 2013
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 40 (1) , 62-66
Ultrasonographic measurement of amniochorionic membrane in asymptomatic pregnant women is not a useful tool for preterm birth prediction
The objective of this study was to determine the accuracy of ultrasonographic measurement of amniochorionic membrane thickness (AMT) in the prediction of preterm birth among an asymptomatic pregnant population.
- 12 August 2013
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 40 (1) , 62-66
Ultrasonographic measurement of amniochorionic membrane in asymptomatic pregnant women is not a useful tool for preterm birth prediction
The objective of this study was to determine the accuracy of ultrasonographic measurement of amniochorionic membrane thickness (AMT) in the prediction of preterm birth among an asymptomatic pregnant population.
- 12 August 2010
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 28 (3) , 153-159
Perinatal Outcomes of Fetal Abdominal Cysts and Comparison of Prenatal and Postnatal Diagnoses
Introduction: The differential diagnosis of an abdominal cyst can be challenging, and an accurate diagnosis is crucial for optimal antenatal management. The aim of this study was to compare the ante- and postnatal diagnoses of cases with abdominal cyst and to determine the diagnostic accuracy of ultrasonography. Material and Methods: A database review was performed regarding the diagnosis of fetal abdominal cyst covering the period 2002–2009. Structural characteristics and localizations of the cysts in the abdomen were recorded. Ante- and postnatal diagnoses were classified into systems according to the origin of the cyst and were compared. Perinatal outcomes were obtained for all cases. Results: 71 cases with an abdominal cyst were identified. The mean gestational age at the time of diagnosis was 25 ± 5.1 weeks. In 9 cases, there were extra-fetal structural abnormalities, and in 5 cases a chromosomal abnormality was determined. Seven pregnancies were terminated. Overall spontaneous mortality was 11/64 (17%). In 12/64 cases (18%), the cyst resolved at birth. After birth, nearly half of the cases required surgical correction and of these, 20% died. Sensitivity, specificity and positive predictive value of ultrasonography in identifying the system of origin were 88.1, 95.7 and 92.0%, respectively, with a 4.1% false-positive rate. Conclusion: Incorporation of different disciplines in the counseling, management and postpartum follow-up is crucial. Postnatal physical examination of fetuses with an abdominal cyst will help to prevent unnecessary surgery.
- 12 August 2010
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 28 (3) , 153-159
Perinatal Outcomes of Fetal Abdominal Cysts and Comparison of Prenatal and Postnatal Diagnoses
Introduction: The differential diagnosis of an abdominal cyst can be challenging, and an accurate diagnosis is crucial for optimal antenatal management. The aim of this study was to compare the ante- and postnatal diagnoses of cases with abdominal cyst and to determine the diagnostic accuracy of ultrasonography. Material and Methods: A database review was performed regarding the diagnosis of fetal abdominal cyst covering the period 2002–2009. Structural characteristics and localizations of the cysts in the abdomen were recorded. Ante- and postnatal diagnoses were classified into systems according to the origin of the cyst and were compared. Perinatal outcomes were obtained for all cases. Results: 71 cases with an abdominal cyst were identified. The mean gestational age at the time of diagnosis was 25 ± 5.1 weeks. In 9 cases, there were extra-fetal structural abnormalities, and in 5 cases a chromosomal abnormality was determined. Seven pregnancies were terminated. Overall spontaneous mortality was 11/64 (17%). In 12/64 cases (18%), the cyst resolved at birth. After birth, nearly half of the cases required surgical correction and of these, 20% died. Sensitivity, specificity and positive predictive value of ultrasonography in identifying the system of origin were 88.1, 95.7 and 92.0%, respectively, with a 4.1% false-positive rate. Conclusion: Incorporation of different disciplines in the counseling, management and postpartum follow-up is crucial. Postnatal physical examination of fetuses with an abdominal cyst will help to prevent unnecessary surgery.
- 1 August 2010
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 36 (2) , 175-178
Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone
- 1 August 2010
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 36 (2) , 175-178
Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone
- 8 June 2010
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 36 (3) , 484-487
Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime
Aim: Moxifloxacin and levofloxacin are wide spectrum quinolones and cefixime is a third‐generation cephalosporin with a wider spectrum of activity against gram‐positive and gram‐negative bacteria and anaerobics. Although they are widely used, little is known about the amniotic fluid levels of these antibiotics. The aim of the present investigation was to study and compare the maternal blood and amniotic fluid levels of these antibiotics in second trimester pregnancy.Methods: To assess the amniotic fluid levels of these antibiotics, 10 pregnant women were given moxifloxacin, 10 were given levofloxacin and 6 were given cefixime orally 2 h before amniocentesis as a single dose for prophylaxis. During amniocentesis, an extra 2 mL amniotic fluid sample and 2 mL maternal venous blood were drawn. The levels of these agents in samples were analyzed using high performance liquid chromatography.Results: The amniotic fluid levels of moxifloxacin and levofloxacin were 0.27 ± 0.21 µg/mL and 0.60 ± 0.41 µg/mL, respectively. The maternal blood levels were 3.53 ± 0.65 µg/mL and 3.95 ± 0.77 µg/mL in the moxifloxacin and levofloxacin groups, respectively. The maternal blood level of cefixime was 2.59 ± 1.10 µg/mL and the amniotic fluid level was 0.85 ± 0.42 µg/mL. The amniotic fluid passage rates were 7.83% for moxifloxacin, 15.67% for levofloxacin and 37.55% for cefixime.Conclusion: Of these three antibiotics, cefixime has the highest transplacental passage rate and, therefore, can be used as a therapeutic agent in infectious conditions in which membranes and the placenta are involved. Moxifloxacin and levofloxacin have low passage rates, which should be considered when using as a therapeutic agent.
- 8 June 2010
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 36 (3) , 484-487
Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime
Aim: Moxifloxacin and levofloxacin are wide spectrum quinolones and cefixime is a third‐generation cephalosporin with a wider spectrum of activity against gram‐positive and gram‐negative bacteria and anaerobics. Although they are widely used, little is known about the amniotic fluid levels of these antibiotics. The aim of the present investigation was to study and compare the maternal blood and amniotic fluid levels of these antibiotics in second trimester pregnancy.Methods: To assess the amniotic fluid levels of these antibiotics, 10 pregnant women were given moxifloxacin, 10 were given levofloxacin and 6 were given cefixime orally 2 h before amniocentesis as a single dose for prophylaxis. During amniocentesis, an extra 2 mL amniotic fluid sample and 2 mL maternal venous blood were drawn. The levels of these agents in samples were analyzed using high performance liquid chromatography.Results: The amniotic fluid levels of moxifloxacin and levofloxacin were 0.27 ± 0.21 µg/mL and 0.60 ± 0.41 µg/mL, respectively. The maternal blood levels were 3.53 ± 0.65 µg/mL and 3.95 ± 0.77 µg/mL in the moxifloxacin and levofloxacin groups, respectively. The maternal blood level of cefixime was 2.59 ± 1.10 µg/mL and the amniotic fluid level was 0.85 ± 0.42 µg/mL. The amniotic fluid passage rates were 7.83% for moxifloxacin, 15.67% for levofloxacin and 37.55% for cefixime.Conclusion: Of these three antibiotics, cefixime has the highest transplacental passage rate and, therefore, can be used as a therapeutic agent in infectious conditions in which membranes and the placenta are involved. Moxifloxacin and levofloxacin have low passage rates, which should be considered when using as a therapeutic agent.